Erythrokeratodermia-cardiomyopathy syndrome: A Patient Guide

Erythrokeratodermia-cardiomyopathy (EKC) syndrome is an exceptionally rare genetic condition that bridges two of the body’s most essential systems: the skin and the heart. The condition is associated with a change in the DSP gene, which provides the instructions for making a protein called desmoplakin. This protein acts as a vital “cellular glue” or anchor, helping to hold cells together in tissues that experience constant mechanical stress. When these anchors are weakened, the skin and the heart muscle can struggle to remain structurally sound, leading to the dual nature of the syndrome ^[1][2].

The most visible part of EKC is the skin involvement, which typically appears in infancy as red, thickened, and scaly patches. These skin changes are often what lead families to seek medical attention initially. However, a critical aspect of the condition is the potential for cardiomyopathy, or heart muscle disease. In individuals with DSP variants, the heart muscle can undergo structural changes—such as the development of scar tissue or the enlargement of the pumping chambers—which can interfere with the heart’s electrical rhythms and pumping strength. Unlike the skin symptoms, this heart involvement is often “silent” in its early stages, meaning it can evolve without causing obvious outward symptoms like shortness of breath or fatigue ^[3][4].

Because the skin and heart symptoms do not always progress at the same rate, managing EKC requires an ongoing, proactive approach. A person may have significant skin challenges while their heart remains stable, or they may have mild skin changes while the heart requires careful medical management. This variability means that regular cardiac imaging and rhythm monitoring are highly recommended, even when a patient feels perfectly healthy. Understanding this relationship allows families and care teams to support both the visible skin symptoms and the internal health of the heart ^[5][6].

While much of the medical literature regarding EKC comes from case reports and small cohorts, identifying the underlying genetic cause allows you and your medical team to implement a personalized care plan. Modern cardiology offers sophisticated tools to monitor heart health, manage symptoms, and guide shared decisions about treatments. By building a multidisciplinary team of specialists—including genetics, dermatology, and inherited cardiology—you can ensure that your care is tailored to your specific needs over time ^[7][8].